Triton Partners’ Post

Moritz Gudenus discusses the initiatives that transformed Bormioli Pharma from a corporate orphan to a leading standalone European manufacturer of plastic and glass pharmaceutical packaging. The sale of Blitz LuxCo Sarl, the holding company of Bormioli Pharma, to Gerresheimer was announced earlier this year and has now closed. It is one of the six realisations Triton has announced across its private equity funds in 2024 so far - representing an aggregate EUR 2.5 billion in value. Bormioli Pharma’s transformation exemplifies Triton’s operational approach to value creation, leveraging West Park’s functional experts across a wide range of areas – including leadership, financing, ESG, and more. Read the full press release here: https://lnkd.in/efdscJ7y Find out more about Triton here: www.triton-partners.com #BuildingBetterBusinesses

Benjamin Stoess

Business Manager @ Gantrade Europe BVBA | Petrochemicals | Business Development, Strategy | MBA

2w

Congratulations! Well done

Like
Reply

To view or add a comment, sign in

Explore topics